Tumour forming Pseudoangiomatous stromal hyperplasia: a case report

Authors

  • Vasuki R. Department of General Surgery, Government Kilpauk Medical College, Chennai, India http://orcid.org/0000-0002-1112-1436
  • Thanmaran N. B. Department of General Surgery, Government Kilpauk Medical College, Chennai, India
  • A. K. Kalpana Devi Department of General Surgery, Government Kilpauk Medical College, Chennai, India
  • Rajesh Menon Moothedath Department of General Surgery, Government Kilpauk Medical College, Chennai, India
  • Satheesh Kumar M. Department of General Surgery, Government Kilpauk Medical College, Chennai, India

DOI:

https://doi.org/10.18203/2349-2902.isj20173435

Keywords:

Breast lump, Core needle biopsy, Hyperplasia, Mammary hamartoma, Myofibroblast, Pueudoangiomatous stromal, Pseudovascular

Abstract

Tumor-forming Pseudoangiomatous stromal hyperplasia (PASH) is a rather uncommon breast lesion and only very few cases of tumor-forming PASH were reported from 1986, since the lesion was originally described. In contrast, focal, non-tumor forming PASH may be an incidental microscopic finding in up to 23% of breast biopsies. PASH is a benign proliferative lesion of the breast stroma that is characterized by slit-like pseudovascular spaces lined by endothelial-like spindle cells. It is indeed rare for a discrete breast mass to have PASH as the main pathological feature on histopathology. The breast mass, typically unilateral, was usually diagnosed clinically as a fibroadenoma.When found in tumour form, PASH most commonly manifests as a single, circumscribed, palpable mass in a premenopausal female. The main differential diagnosis histologically are fibroadenoma, phyllodes tumor and angiosarcoma. However, PASH is a benign condition with very good prognosis. Hence possibility of PASH in nodular or tumour form has to be considered when approaching a case of breast lump whose management is different. We report here a case of PASH in tumour form from our Institute.

Metrics

Metrics Loading ...

References

Vuitch MF, Rosen PP, Erlandson RA, Pseudoangiomatous hyperplasia of mammary stroma. Human Pathol. 1986;17(2):185-91.

Ibrahim RE, Sciotto CG, Weidner N. Pseudoangiomatous hyperplasia of mammary stroma. Some observations regarding its clinicopathologic spectrum. Cancer. 1989;63:1154-60.

Leon ME, Leon MA, Ahuja J, Garcia FU. Nodular myofibroblastic stromal hyperplasia of the mammary gland as an accurate name for pseudoangiomatous stromal hyperplasia of the mammary gland. Breast J. 2002;8(5):290-3.

Powell CM, Cranor ML, Rosen PP. Pseudoangiomatous stromal hyperplasia (PASH): a mammary stromal tumour with myofibroblastic differentiation. Am J Surg Pathol. 1995;19:270.

Ferreira M, Albarracin CT, Resetkova E. Pseudoangiomatous stromal hyperplasia tumor: a clinical, radiologic and pathologic study of 26 cases. Mod Pathol. 2008;21(2):201-7.

Bowman E, Oprea G, Okoli J, Gundry K, Rizzo M, Gabram-Mendola S, et al. Pseudoangiomatous Stromal Hyperplasia (PASH) of the Breast: a series of 24 Patients. Breast J. 2012;18(3):242-7.

Rosen PP (ed). Rosen's Breast Pathology, 2nd edn. Lippincott Williams and Wilkins: Philadelphia, PA. 2001:757-66.

Cohen MA, Morris EA, Rosen PP, Dershaw DD, Liberman L, Abramson AF et al. Pseudoangiomatous stromal hyperplasia: mammographic, sonographic, and clinical patterns. Radiol. 1996;198(1):117-20.

Polger MR, Denison CM, Lester S, Meyer JE. Pseudoangiomatous stromal hyperplasia: imaging findings with pathologic and clinical correlation. Am J Roentgenol. 2010;195(4):1036-42.

Polger MR, Denison CM, Lester S, Meyer JE. Pseudoangiomatous stromal hyperplasia: mammographic and sonographic appearances. Am J Roentgenol. 1996;166(2):349-52.

Analysis of the mammographic and sonographic features of pseudoangiomatous stromal hyperplasia. Am J Roentgenol. 2008;191(2):359-63.

Choi YJ, Ko EY, Kook S. Diagnosis of pseudoangiomatous stromal hyperplasia of the breast: ultrasonography findings and different biopsy methods. Yonsei Med J. 2008;49(5):757-64.

Virk RK, Khan A. Pseudoangiomatous stromal hyperplasia: an overview. Arch Pathol Lab Med. 2010;134(7):1070-4.

Degnim AC, Frost MH, Radisky DC, Anderson SS, Vierkant RA, Boughey JC, et al. Pseudoangiomatous stromal hyperplasia and breast cancer risk. Annals Surg Oncol. 2010;17(12):3269-77.

Pruthi S, Reynolds C, Johnson RE, Gisvold JJ. Tamoxifen in the management of pseudoangiomatous stromal hyperplasia. Breast J. 2001;7:434-9.

Downloads

Published

2017-07-24

How to Cite

R., V., N. B., T., Devi, A. K. K., Moothedath, R. M., & M., S. K. (2017). Tumour forming Pseudoangiomatous stromal hyperplasia: a case report. International Surgery Journal, 4(8), 2854–2857. https://doi.org/10.18203/2349-2902.isj20173435

Issue

Section

Case Reports